News    Sports    Entertainment Log In    My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Sunday, March 21, 2010 10:14 AM

GlaxoSmithKline plc

GlaxoSmithKline plc
GlaxoSmithKline plc
Type: Company
Name: GlaxoSmithKline plc (GlaxoSmithKline Pharmaceuticals Ltd, GlaxoSmithKline Consumer Healthcare Limited)
Nationality: United Kingdom
Web Address: http://www.gsk.com/
Fact Sheet: Fact Sheet for GlaxoSmithKline plc
First Reported 6 hours ago - Updated 6 hours ago - 1 Documents
AstraZeneca PLC
AstraZeneca PLC

AstraZeneca to cut staff, cease research into 10 diseases

AstraZeneca, the Anglo-Swedish pharmaceutical group, is to reduce its staff, shut operations, and cease research into several diseases as part of a wide ranging restructuring, the UK's Financial Times reports.The company will close some research centres ... [Published 6 hours ago by Pharmacy Today]
First Reported 15 hours ago - Updated 15 hours ago - 1 Documents
Food and Drug Administration
Food and Drug Administration

Is It Ethical for Drug Companies to Pay Off Doctors?

Appearance of improprietyIn the late 90's, the Food and Drug Administration issued a rule change that made it legal for pharmaceutical companies to advertise their products on television. And so began the Era of Amusing Disclaimers, where 75% of the typical ... [Published 15 hours ago by 411mania.com]
First Reported Mar 20 2010 - Updated Mar 20 2010 - 1 Documents
GlaxoSmithKline plc
GlaxoSmithKline plc

GlaxoSmithKline updates packaging to maximize Tums brand

Although the Tums brand has been gracing American medicine cabinets for more than 75 years, the... ... [Published Mar 20 2010 by Packaging Digest]
First Reported Mar 20 2010 - Updated Mar 20 2010 - 1 Documents

Nabi Vaccine Program Advances

Nabi Biopharmaceuticals (NASDAQ:NABI)In November 2009, Nabi and GlaxoSmithKline (NYSE:GSK)Nabi has the potential to receive double-digit royalties from sales if the product is commercialized. GlaxoSmithKline will have an option to exclusively in-license ... [Published Mar 20 2010 by Daily Markets]
First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

Glaxo takes 19 percent of Aspen

GlaxoSmithKline has taken a 19 percent stake in Africa's biggest generic drugmaker, Aspen Pharmacare , after completing a strategic collaboration with the South African group, the companies said on Tuesday. ... [Published Mar 19 2010 by International Business Times UK]
First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

Patent tax scheme encourages Glaxo to invest in UK

GlaxoSmithKline Plc plans to increase its investment in Britain following a government decision to slash corporation tax for patent-derived income. ... [Published Mar 19 2010 by International Business Times UK]
First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

GlaxoSmithKline accused of skewing debate on drug safety

Out of hours press enquiries, call 07918 083 774More than 90 per cent of scientists who backed a drug at the centre of a safety scare had financial links to the pharmaceutical industry, and 87 per cent had financial links with the drug's manufacturer, ... [Published Mar 19 2010 by Animal Aid]
First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

Research and Markets: Polish Pharmaceutical Companies Bioton and Polpharma Have Announced They Are Investigating the Possibility

has announced the addition of the " The Poland Pharmaceuticals and Healthcare Report provides industry BMI considers Poland's pharmaceutical market reasonably attractive to Environment Ratings, Poland places seventh out of the 20 Central andEastern European ... [Published Mar 19 2010 by EuroInvestor.co.uk]
First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

Broker Roundup Update: Brokers favour GSK

* Citigroup has a buy and 135p target for Aegis, a buy and ?2.95 target for C&C, a buy and £14.20 target for GlaxoSmithKline and a speculative buy and 150p target for Vectura  * Ambrian initiates coverage of GlaxoSmithKline with a buy and AstraZeneca ... [Published Mar 19 2010 by Citywire]
First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

NSE: Market Dips Marginally

Transactions on the floor of Nigerian Stock Exchange yesterday ended on a negative note as market indicators went down marginally.Specifically, market closed lower at 24,262.34 points, in contrast to Wednesday closing of 24,447.85, depreciating by 185.51 ... [Published Mar 19 2010 by The Tide Online]
First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

Britain's top share index 0.2% higher

Britain’s top share index 0.2% higherLONDON: Britain’s top share index edged 0.2 percent higher on Thursday, driven by strength from drugmakers and energy stocks, while banks fell back after recent gains.By 1209 GMT the FTSE 100 was up 10.82 points, or ... [Published Mar 19 2010 by Daily Times]
First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

Let the sun shine in

Doctors should be required to tell their patients if they are on the payroll of a pharmaceutical company, and those companies should have to disclose their payments to doctors.Health food stores sell an array of fish oil supplements for an annual cost ... [Published Mar 19 2010 by Milwaukee Journal Sentinel]

Quotes

Another concern raised in Fauber's article is doctors speaking on behalf of drug companies "can be biased and contribute to spiraling health care costs by promoting the use of expensive brand-name drugs over generics." Insured patients are likely to choose brand-name drugs, because a third-party is paying the majority, if not the entirety, of the cost...
Is It Ethical for Drug Companies to Pay Off Doctors? [411mania.com - 15 hours ago]

More Content

All (3576) | News (3286) | Reports (3) | Blogs (246) | Audio/Video (1) | Fact Sheets (32)
sort by: Date | Relevance
Cipla to replace Sun Pharma in Sensex [Economictimes - 1 hour ago]
Cipla to replace Sun Pharma in Sensex from May 3 [Economictimes - 1 hour ago]
New Market Report: MarketWatch: Drinks - Januar... [PR inside - 3 hours ago]
AstraZeneca to cut staff, cease research into 1... [Pharmacy Today - 6 hours ago]
A review of the prevention and treatment of ven... [Formulary Journal - 6 hours ago]
Takeda pulls diabetes combo filing in Europe [Pharma Times - 6 hours ago]
New study to show how our body clock controls d... [Media Newswire - 13 hours ago]
Is It Ethical for Drug Companies to Pay Off Doc... [411mania.com - 15 hours ago]
FDA actions in brief, March 2010 (Iprivask, VPR... [Modern Medicine - 20 hours ago]
FDA imposes new safety requirements to curb use... [Modern Medicine - 20 hours ago]
FDA Pipeline preview, March 2010 (CPI-300, Onda... [Modern Medicine - 20 hours ago]
FDA actions in brief, March 2010 (Iprivask, VPR... [Formulary Journal - Mar 20 2010]
GlaxoSmithKline updates packaging to maximize T... [Packaging Digest - Mar 20 2010]
Study: Researchers with Glaxo ties favored Avandia [Philadelphia Inquirer - Mar 20 2010]
Africa to receive H1N1 vaccine soon [Radio Netherlands - Mar 20 2010]
Abbott Inks Deal to Develop Companion Diagnosti... [Laboratory Industry Report - Mar 20 2010]
Australia's pharmaceuticals and healthcare mark... [News-Medical.Net - Mar 20 2010]
Australia Pharmaceuticals and Healthcare Report... [Pharmacy Choice - Mar 20 2010]
Graduate careers: Public sector a class apart [Guardian.co.uk - Mar 20 2010]
3/19/10 - Glenmark Generics wins FDA approval f... [Pharmacy Choice - Mar 20 2010]
Will a fresh look at pain overcome drug barriers? [DAWN Group - Mar 20 2010]
Glenmark Generics wins FDA approval for hyperte... [Pharmacy Choice - Mar 20 2010]
Drugmakers, non-profits to partner on TB drug d... [FierceBiotech - Mar 20 2010]
Nabi Vaccine Program Advances [Daily Markets - Mar 20 2010]
Isa Insight: UK stock market [Times Online - Mar 19 2010]
Glaxo takes 19 percent of Aspen [International Business Times UK - Mar 19 2010]
Patent tax scheme encourages Glaxo to invest in UK [International Business Times UK - Mar 19 2010]
Market near 2 Month high amid positive global cues [Business Today - Mar 19 2010]
Markets opened on a flat note to positive note [Business Today - Mar 19 2010]
Phase III asthma programme is underway [Pharmacy Europe - Mar 19 2010]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
Andrew Witty, Abbas Hussain, Jean Stéphenne, [more]
  •  
AstraZeneca PLC, Xenoport Inc, Novartis AG, [more]
  •  
Food and Drug Administration, World Health Organization, US Senate, [more]
  •  
Vaccine, Swine Flu Vaccine, FTSE 100, [more]
  •  
Avandia, Relenza, Cervarix, [more]
  •  
London, Nashik, Verona (Italy), [more]
  •  
United Kingdom, United States, India, [more]
  •  
Medicine, Medication, Biology, [more]
  •  
Pharma & Biotech, Health, IT, [more]
ShareCast, This Is Money, Times Online, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Glaxo's Asthma Drug Looks Increasingly Bullet-P... [Biotech Sector and Stocks Analysis from Seeking ... - Mar 19 2010]
EP Vantage submits:Not many events have sufficient gravitas to move shares in £64bn ($103bn) GlaxoSmithKline (GSK) these days, a fact that puts the significance ...
Glaxo's Asthma Drug Looks Increasingly Bullet-P... [Healthcare Sector and Stocks Analysis from Seek ... - Mar 19 2010]
EP Vantage submits:Not many events have sufficient gravitas to move shares in £64bn ($103bn) GlaxoSmithKline (GSK) these days, a fact that puts the significance ...
Most Avandia Supporters Have Ties To Glaxo [Pharmalot - Mar 19 2010]
And so the debate over untoward conflicts of interest rages on. The latest installment is brought to you by BMJ, which has published a paper by a team of Mayo Clinic ...
Teva Could Be Seeking Mega-Cap Status (TEVA, PF... [BioHealth Investor - Mar 18 2010]
Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) is slowly becoming one of the biggest drug makers in the world.  This morning the company is up on the news ...
FDA To Devise New Guidelines For Drug Cocktails [Pharmalot - Mar 18 2010]
The move is designed to jumpstart testing and approval of new regimens for so-called drug cocktails to combat tuberculosis, AIDS and cancer. The guidelines would ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Mandy Moore Joins Fight Against Cervical Cancer [Associated Press - YouTube - Jan 26 2010]
1
Products & Services
Silobreaker.com
Enterprise Online Service
Enterprise Software Suite
Widgets & API
How To Use
Silobreaker
RSS
API
Widgets
Advertise With Us
Advertise
Follow Us
Press Room
Blog
YouTube
Twitter
About Us
About Silobreaker
Background and History
Why Silobreaker?
Value Proposition
Technology
Team
Contact Us
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2009 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.